Ambulatory Electrocardiography, commonly known as Holter Monitoring, serves as a non-invasive diagnostic tool to evaluate and track the heart's electrical activity over an extended timeframe, typically ranging from 24 to 48 hours. Named after its innovator, Dr. Norman J. Holter, this portable apparatus continuously records the heart's rhythm, offering a comprehensive overview of cardiac function during an individual's daily routine. Utilizing small electrodes affixed to the chest, the lightweight Holter monitor is discreetly worn on a belt or shoulder strap. This method of monitoring proves invaluable in identifying irregularities or anomalies that may escape notice during a brief clinical visit. Holter monitoring finds widespread application in diagnosing arrhythmias, assessing the efficacy of anti-arrhythmic medications, and investigating unexplained symptoms like palpitations, dizziness, or fainting episodes. The data amassed by the Holter monitor empowers healthcare practitioners to scrutinize the heart's electrical patterns, enabling informed decisions regarding suitable treatments or interventions.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States